Consensus LeMaitre Vascular, Inc. Börse Stuttgart

Equities

LHU

US5255582018

Market Closed - Börse Stuttgart Other stock markets 01:25:36 02/07/2024 am IST			5-day change	1st Jan Change
74.5 ^EUR	-2.61%		-0.67%	+43.27%

03/06	Lemaitre Vascular, Inc. Announces Resignation of Lawrence J. Jasinski as A Director	CI
31/05	Roth MKM Upgrades LeMaitre Vascular to Buy Rating With $100 Price Target	MT

Evolution of the average Target Price on LeMaitre Vascular, Inc.

Price target over the last 5 years

History of analyst recommendation changes

d7f4779d.502OAoJlHvLekcV7ItEpKFhtWXY7XdXZ4rcSqryKT18.0j_AZrUzWqC797MSUud_HjAKFzIKNeyOmPQqy_PVB2aBPNdMzjRGoZ3liA~3c846d9360d504b40684a07b4f4009ad

Analyst Recommendations on LeMaitre Vascular, Inc.

Roth MKM Upgrades LeMaitre Vascular to Buy Rating With $100 Price Target	31/05	MT
Lemaitre Vascular Insider Sold Shares Worth $9,314,501, According to a Recent SEC Filing	09/05	MT
Lemaitre Vascular Insider Sold Shares Worth $379,991, According to a Recent SEC Filing	09/05	MT
Barrington Boosts Price Target on LeMaitre Vascular to $79 From $69, Keeps Outperform Rating	03/05	MT
Stifel Upgrades LeMaitre Vascular to Buy From Hold, Adjusts Price Target to $75 From $59	26/04	MT
Barrington Raises Price Target on LeMaitre Vascular to $69 From $66, Keeps Outperform Rating	28/02	MT
JMP Securities Initiates LeMaitre Vascular With Market Outperform Rating, Price Target is $60	23/23/23	MT
Oppenheimer Initiates Coverage on LeMaitre Vascular With Outperform Rating, $70 Price Target	06/23/06	MT
Jefferies Downgrades LeMaitre Vascular to Hold From Buy, Adjusts Price Target to $67 From $63	03/23/03	MT
Barrington Raises Price Target on LeMaitre Vascular to $66 From $62, Maintains Outperform Rating	02/23/02	MT
Stifel Raises LeMaitre Vascular's Price Target to $60 From $48, Hold Rating Kept	03/23/03	MT
Jefferies Raises LeMaitre Vascular's Price Target to $63 From $57, Maintains Buy Rating	03/23/03	MT
Roth MKM Raises LeMaitre Vascular's Price Target to $54 From $48, Neutral Rating Kept	03/23/03	MT
Barrington Research Upgrades LeMaitre Vascular to Outperform From Market Perform	03/23/03	MT
Barrington Research Downgrades LeMaitre Vascular to Market Perform From Outperform	28/22/28	MT
Barrington Lowers LeMaitre Vascular's Price Target to $50 From $54, Maintains Outperform Rating	29/22/29	MT
Barrington Research Trims LeMaitre Vascular's Price Target to $54 From $62, Maintains Outperform Rating	25/22/25	MT
Barrington Adjusts Price Target on LeMaitre Vascular to $62 From $64, Maintains Outperform Rating	29/21/29	MT
LEMAITRE VASCULAR : Jefferies Initiates LeMaitre Vascular at Buy Rating With $70 Price Target	16/21/16	MT
LEMAITRE VASCULAR : Roth Capital Adjusts LeMaitre Vascular's Price Target to $58 from $55, Keeps Neutral Rating	03/21/03	MT
LEMAITRE VASCULAR : Barrington Adjusts Price Target on LeMaitre Vascular to $64 From $59, Maintains Outperform Rating	30/21/30	MT
LEMAITRE VASCULAR : Roth Capital Adjusts LeMaitre Vascular PT to $55 From $53, Maintains Neutral Rating	04/21/04	MT
LEMAITRE VASCULAR : Barrington Adjusts Price Target on LeMaitre Vascular to $59 From $49, Maintains Outperform Rating	01/21/01	MT
LEMAITRE VASCULAR : Barrington Adjusts LeMaitre Vascular PT to $49 From $47, Maintains Outperform Rating	26/21/26	MT
LEMAITRE VASCULAR : KeyBanc Starts LeMaitre Vascular at Sector Weight	12/21/12	MT